Robert J. Decker - 27 Feb 2026 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Signature
/s/ Joleen Morgan, as attorney-in-fact for Robert J. Decker
Issuer symbol
JNJ
Transactions as of
27 Feb 2026
Net transactions value
-$538,715
Form type
4
Filing time
03 Mar 2026, 16:21:53 UTC
Previous filing
18 Feb 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Decker Robert J VP Corporate Controller ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK /s/ Joleen Morgan, as attorney-in-fact for Robert J. Decker 03 Mar 2026 0001798703

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $471,355 +4,075 +17% $115.67 27,757 27 Feb 2026 Direct
transaction JNJ Common Stock Sale $1,010,070 -4,075 -15% $247.87 23,682 27 Feb 2026 Direct
holding JNJ Common Stock 134 27 Feb 2026 By ESOP F1
holding JNJ Common Stock 646 27 Feb 2026 By 401k F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Employee Stock Options (Right to Buy) Options Exercise $0 -4,075 -100% $0.000000 0 27 Feb 2026 Common Stock 4,075 $115.67 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2026).
F2 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (2/28/2026).
F3 Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.